UK Children’s Healthcare Market Report 2025
Not all parents are confident in offering effective healthcare to their children, with 19% saying they don't feel confident knowing which non-prescription remedies can be used together.
Not all parents are confident in offering effective healthcare to their children, with 19% saying they don't feel confident knowing which non-prescription remedies can be used together.
Not all parents are confident in offering effective healthcare to their children, with 19% saying they don’t feel confident knowing which non-prescription remedies can be used together. This signals a need for brands to provide more guidance to empower parents to give their children the best care possible.
The primary threat to the category is the declining birth rate, reducing demand for products in the category in the long-term. This will mean brands, and the category, will struggle to grow.
However, brands have significant opportunities to evolve products and marketing to align with consumer needs. For example, 55% of parents who have used a pain relief product for their child have done so to ease an exercise-related ailment. Marketing and topical analgesics that tap into this unmet need can drive spending.
The children’s healthcare category faces a declining birth rate, forcing brands to pivot and innovate to manage the impact of reduced demand.
Georgia Stafford, Beauty & Personal Care Analyst
For the purposes of this Report, Mintel has used the following definitions:
Children are defined as those aged 0-15.
As well as reviewing general attitudes and behaviours towards children’s health, this Report covers the market for children’s OTC and healthcare products, including remedies for the following ailments suffered by children:
A market size has been produced based on children’s OTC remedies for the above ailments, excluding products for head lice, skin conditions, and teething pain.
OTC medicines are defined as products with either a ‘P’ or ‘GSL’ licence, issued under the Medicines Act 1968 and related EU (European Union) legislation, and enforced by the MHRA (Medicines and Healthcare products Regulatory Agency) and the CHM (Commission on Human Medicines). They are defined by the Proprietary Association of Great Britain as being:
“Specifically designed to treat the symptoms of common, minor and self-limiting ailments that do not require a medical diagnosis.”
The two categories of OTC medicines are:
Excluded: